Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DGF”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Not applicableActive Not RecruitingNCT04414111
What this trial is testing

Highly Suppressive Treg in Delayed and Slow Graft Function After Kidney Transplantation

Who this might be right for
DGFKidney Transplant; Complications
St. Louis University 180
Testing effectiveness (Phase 2)Study completedNCT02134314
What this trial is testing

C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI

Who this might be right for
End Stage Renal DiseaseKidney FailureDelayed Graft Function+1 more
Cedars-Sinai Medical Center 70
Large-scale testing (Phase 3)UnknownNCT02474667
What this trial is testing

Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney

Who this might be right for
Delayed Graft Function
Angion Biomedica Corp 253
Testing effectiveness (Phase 2)Ended earlyNCT01919346
What this trial is testing

Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation

Who this might be right for
Delayed Graft FunctionKidney TransplantationComplement Activity
Heeger, Peter, M.D. 21
Not applicableStudy completedNCT06626724
What this trial is testing

A Retrospective Cohort Study on Predicting Delayed Graft Function in Liver Transplant Patients with Hepatocellular Carcinoma: a Nomogram and Machine Learning Approaches.

Who this might be right for
Hepatocellular Carcinoma (HCC)DGF
Jian You 131
Post-approval studies (Phase 4)Study completedNCT03864926
What this trial is testing

Envarsus in Delayed Graft Function (E-DGF)

Who this might be right for
Delayed Graft Function
University of Wisconsin, Madison 100
Post-approval studies (Phase 4)UnknownNCT01663805
What this trial is testing

Effects of the Use of "de Novo" Everolimus in Renal Tranplant Population

Who this might be right for
Delayed Function of Renal Transplant
MARIO ABBUD FILHO 80
Post-approval studies (Phase 4)Study completedNCT00154232
What this trial is testing

Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 46
Large-scale testing (Phase 3)Looking for participantsNCT07020832
What this trial is testing

Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation

Who this might be right for
Delayed Graft FunctionEnd Stage Renal DiseaseDeceased Donor Kidney Transplant
Apellis Pharmaceuticals, Inc. 320
Testing effectiveness (Phase 2)UnknownNCT01561599
What this trial is testing

Study on Delayed Graft Function Using Paired Kidneys

Who this might be right for
Delayed Graft Function
Angion Biomedica Corp 12
Testing effectiveness (Phase 2)Ended earlyNCT02723786
What this trial is testing

Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation

Who this might be right for
Kidney Transplantation (Status Post)
GlaxoSmithKline 7
Testing effectiveness (Phase 2)Looking for participantsNCT07275632
What this trial is testing

The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients

Who this might be right for
Delayed Graft FunctionKidney Transplantation
First Affiliated Hospital of Chongqing Medical University 47
Testing effectiveness (Phase 2)Study completedNCT04696146
What this trial is testing

Berinert (C1INH) vs Placebo for DGF/IRI

Who this might be right for
End Stage Renal DiseaseChronic Kidney Diseases
Cedars-Sinai Medical Center 45
Large-scale testing (Phase 3)Looking for participantsNCT06830798
What this trial is testing

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

Who this might be right for
Delayed Graft FunctionDGFKidney Transplant
Alexion Pharmaceuticals, Inc. 450
Not applicableActive Not RecruitingNCT07392996
What this trial is testing

Does Early Postoperative Fluid Management Affect Functional Delayed Graft Function After Living Donor Kidney Transplantation?

Who this might be right for
Renal TransplantDGF
Ankara University 122
Post-approval studies (Phase 4)Ended earlyNCT02056938
What this trial is testing

ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF

Who this might be right for
Kidney Transplantation
Nantes University Hospital 19
Testing effectiveness (Phase 2)WithdrawnNCT02312115
What this trial is testing

Delayed Renal Allograft Function and Furosemide Treatment

Who this might be right for
Delayed Graft Function
Loma Linda University
Not applicableLooking for participantsNCT06130046
What this trial is testing

MR-proADM as a Early Biomarker for DGF and AR in Kidney and Liver Transplantation

Who this might be right for
Kidney Transplant; ComplicationsLiver Transplant; Complications
University of Rome Tor Vergata 300
Post-approval studies (Phase 4)WithdrawnNCT02130817
What this trial is testing

Belatacept in Kidney Transplantation of Moderately Sensitized Patients

Who this might be right for
End Stage Renal DiseaseAntibody Mediated Rejection
University of Wisconsin, Madison
Large-scale testing (Phase 3)Study completedNCT02145182
What this trial is testing

Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)

Who this might be right for
Delayed Graft Function
Alexion Pharmaceuticals, Inc. 288